Life sciences organizations drove a wave of innovation during the pandemic, introducing new treatment methods, advanced analytics, and digital connectivity that helped countless people navigate the crisis. Now, as these companies move beyond disruption to address new global and industry challenges, leaders are asking, "What's next?" to boost value and profitability.

​

In response, life sciences leaders are once again aiming high, with technology as their focus. Maximizing value from cloud and digital is essential, yet the potential of artificial intelligence (AI) — particularly generative AI — is vast for the life sciences. But where should you begin?